The study has been designed as a feasibility study as there are believed to be too many unknown factors to proceed directly to definitive randomised controlled study design. These are outlined in full in section 11A. It is predicted recruitment will begin in May 2016 and continue until November 2018. Final follow-up assessment will occur one year after initial outcome assessment. So it is predicted that final patient contact will occur in October/November 2019.